Mukund Chorghade Ph.D. has over 35 years of experience in drug discovery, chemical route selection, process development and formulations design for academic and industry-sponsored research on New Chemical Entities and generics. He currently serves as President and Chief Scientific and Technology Officer, THINQ Pharmaceuticals, where he researches drugs derived from Traditional Indian Medicine. He consults for American and European pharmaceutical companies on worldwide collaborations with academic, government and industrial laboratories.

Previously, Dr. Chorghade served as Chief Scientific Officer at Empiriko, a biotech company and Vice-President of Chemical Development Sciences at Geltex/Genzyme where he oversaw projects in transitioning New Chemical Entities from concept to commercialization (or bench to bedside). He also directed research groups at Dow Chemicals, Abbott Laboratories and CytoMed.

Dr. Chorghade earned his B.S. and M.S. degrees from the University of Poona in India. He holds a Ph.D. in organic chemistry from Georgetown University, Washington D.C., and completed postdoctoral appointments at the University of Virginia and Harvard University, visiting scientist appointments at University of British Columbia, Vancouver, Canada and College de France / Universite’ Louis Pasteur. He received his D.Sc. degree from the University of Mumbai in December 2021.

Dr. Chorghade has been the recipient of three “Scientist of the Year Awards” and gold medals for his research; He is an elected fellow in prestigious academies and societies (AAAS, ACS, AIC, ICS, ISCB, Sigma Xi, RACI, and RSC) and had the honor of being a featured speaker in several national and international symposia. He is the Sigma Xi Distinguished Speaker (2022-2024). He has published 5 books and hundreds of articles in drug discovery and development.

Dr. Chorghade is an adjunct faculty member at Harvard, MIT, Rutgers, University of Illinois, Cambridge University and Strathclyde Universities (UK). He serves on the board of directors of the Princeton Section of the American Chemical Society and on numerous international and U.S. scientific advisory boards.